FDA Inspection 1228269 — Joaquin Martinez Lopez, MD, PhD.
The FDA completed an inspection of Joaquin Martinez Lopez, MD, PhD. on Jan 12, 2024 in Madrid. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Madrid (Spain)
Additional details
Clinical Investigator (CI)